JPM Thematics - Genetic Therapies C (dist) - GBP/  LU2314628723  /

Fonds
NAV16/05/2024 Diferencia-0.8700 Tipo de beneficio Enfoque de la inversión Sociedad de fondos
64.7300GBP -1.33% paying dividend Equity Worldwide JPMorgan AM (EU) 

Estrategia de inversión

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally. Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.
 

Objetivo de inversión

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
 

Datos maestros

Tipo de beneficio: paying dividend
Categoría de fondos: Equity
Región: Worldwide
Sucursal: Sector Health / Pharma
Punto de referencia: MSCI All Country World Index (Total Return Net)
Inicio del año fiscal: 01/07
Última distribución: 13/09/2023
Banco depositario: J.P. Morgan SE - Zweigniederlassung Luxemburg
País de origen: Luxembourg
Permiso de distribución: Austria, Germany, Switzerland, Luxembourg
Gestor de fondo: Yazann Romahi, Aijaz Hussain
Volumen de fondo: 625.11 millones  USD
Fecha de fundación: 17/03/2021
Enfoque de la inversión: -

Condiciones

Recargo de emisión: 0.00%
Max. Comisión de administración: 0.36%
Inversión mínima: 10,000,000.00 GBP
Deposit fees: -
Cargo por amortización: 0.00%
Prospecto simplificado: Descargar (Versión para imprimir)
 

Sociedad de fondos

Fondos de empresa: JPMorgan AM (EU)
Dirección: PO Box 275, 2012, Luxembourg
País: Luxembourg
Internet: www.jpmorganassetmanagement.de
 

Activos

Stocks
 
99.37%
Mutual Funds
 
0.63%

Países

United States of America
 
76.62%
Switzerland
 
8.07%
Japan
 
5.63%
Germany
 
2.30%
Australia
 
1.91%
France
 
1.31%
China
 
1.00%
Taiwan, Province Of China
 
0.72%
Netherlands
 
0.66%
Korea, Republic Of
 
0.62%
Singapore
 
0.32%
United Kingdom
 
0.24%
Otros
 
0.60%

Sucursales

Pharma/Biotechnology
 
87.07%
Healthcare services
 
11.49%
Healthcare appliances
 
0.78%
Otros
 
0.66%